Overview

* 3D Systems ( DDD ) Q2 revenue declines 16% year-over-year, missing analyst expectations

* Net income rises significantly due to gains from asset sales and debt extinguishment

* Adjusted EBITDA improves, driven by cost reductions

Outlook

* Company anticipates continued impact of tariffs on operating costs

* 3D Systems ( DDD ) expects growth in medical markets to continue

* Company projects future growth in Aerospace & Defense market

* 3D Systems ( DDD ) aims for positive cash flow by 2026

Result Drivers

* MEDICAL TECHNOLOGY - Double-digit growth in Medical Technology market driven by orthopedic procedures and expansion into trauma-related surgeries

* AEROSPACE & DEFENSE - Strong demand in Aerospace & Defense sector, with revenues up 84% year-over-year

* COST SAVINGS - Over $20 mln saved in operating expenses through cost reduction and efficiency programs

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Miss $94.80 $95.70

Revenue mln mln (4

Analysts

)

Q2 -$0.07

Adjusted

EPS

Q2 EPS $0.57

Q2 Net $104.40

Income mln

Q2 -$5.30 -$13.70

Adjusted mln mln (3

EBITDA Analysts

)

Q2 Gross 38.1%

Margin

Q2 39.2%

Adjusted

Gross

Margin

Q2 -$15.40

Operatin mln

g Income

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the electronic equipment & parts peer group is "buy."

* Wall Street's median 12-month price target for 3D Systems Corp ( DDD ) is $2.00, about 11% above its August 8 closing price of $1.78

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)